A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation
Peter W. Radke, Hans R. Figulla, Helmut Drexler, Heinrich G. Klues, Andreas Mügge, Sigmund Silber, Werner Daniel, Alexander Schmeisser, Nicolaus Reifart, Wolfgang Motz, Hans-Joachim Büttner, Dieter FiVolume:
152
Year:
2006
Language:
english
Pages:
65535
DOI:
10.1016/j.ahj.2006.07.003
File:
PDF, 131 KB
english, 2006